Profil
Erin Boyer currently works at uniQure NV, as Chief People & Culture Officer from 2022.
Ms. Boyer also formerly worked at Obsidian Therapeutics, Inc., as Vice President-Human Resources, Alnylam Pharmaceuticals, Inc., as Head-Global Talent Strategy & Planning from 2017 to 2019, and Epizyme, Inc., as Chief People & Culture Officer from 2020 to 2022.
Ms. Boyer received her undergraduate degree from Macalester College.
Aktiva positioner av Erin Boyer
| Företag | Position | Start |
|---|---|---|
| UNIQURE N.V. | Personalchef | 2022-04-01 |
Tidigare kända positioner av Erin Boyer
| Företag | Position | Slut |
|---|---|---|
| EPIZYME, INC. | Personalchef | 2022-04-01 |
| ALNYLAM PHARMACEUTICALS, INC. | Företagsledare/Principal | 2019-09-01 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Personalchef | - |
Erin Boyers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Macalester College
Macalester College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
















